1. Home
  2. CING vs NCL Comparison

CING vs NCL Comparison

Compare CING & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • NCL
  • Stock Information
  • Founded
  • CING 2012
  • NCL 2013
  • Country
  • CING United States
  • NCL United States
  • Employees
  • CING N/A
  • NCL N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • NCL
  • Sector
  • CING Health Care
  • NCL
  • Exchange
  • CING Nasdaq
  • NCL Nasdaq
  • Market Cap
  • CING 13.1M
  • NCL 11.6M
  • IPO Year
  • CING 2021
  • NCL 2023
  • Fundamental
  • Price
  • CING $4.36
  • NCL $0.30
  • Analyst Decision
  • CING Strong Buy
  • NCL
  • Analyst Count
  • CING 4
  • NCL 0
  • Target Price
  • CING $30.67
  • NCL N/A
  • AVG Volume (30 Days)
  • CING 97.0K
  • NCL 619.0K
  • Earning Date
  • CING 05-07-2025
  • NCL 05-19-2025
  • Dividend Yield
  • CING N/A
  • NCL N/A
  • EPS Growth
  • CING N/A
  • NCL N/A
  • EPS
  • CING N/A
  • NCL N/A
  • Revenue
  • CING N/A
  • NCL $15,576,857.00
  • Revenue This Year
  • CING N/A
  • NCL N/A
  • Revenue Next Year
  • CING N/A
  • NCL N/A
  • P/E Ratio
  • CING N/A
  • NCL N/A
  • Revenue Growth
  • CING N/A
  • NCL 47.13
  • 52 Week Low
  • CING $1.80
  • NCL $0.15
  • 52 Week High
  • CING $20.83
  • NCL $0.69
  • Technical
  • Relative Strength Index (RSI)
  • CING 57.77
  • NCL 77.51
  • Support Level
  • CING $4.03
  • NCL $0.20
  • Resistance Level
  • CING $4.44
  • NCL $0.31
  • Average True Range (ATR)
  • CING 0.29
  • NCL 0.02
  • MACD
  • CING 0.04
  • NCL 0.01
  • Stochastic Oscillator
  • CING 74.38
  • NCL 91.38

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.

Share on Social Networks: